World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
51
Citations
7801
World Ranking
17323
National Ranking
7121

Mary K. Danks publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Mary K. Danks sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 107 publications — 7th percentile

7% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Mary K. Danks D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Mary K. Danks sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 51 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Mary K. Danks is affiliated with St. Jude Children's Research Hospital in the United States. Their research primarily spans the fields of Medicine, and Biochemistry, Genetics and Molecular Biology, with a notable focus on subfields such as Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research, and Pharmacology.

The scientist has contributed extensively to topics involving Sarcoma Diagnosis and Treatment, Cancer Genomics and Diagnostics, Molecular Biology Techniques and Applications, CAR-T cell therapy research, Cancer Cells and Metastasis, Ear and Head Tumors, and Cholinesterase and Neurodegenerative Diseases.

Mary K. Danks's publication record includes recent papers in reputed journals and venues. Selected works include:

  • "Crystal structure of human carboxylesterase 1 complexed with the Alzheimer's drug tacrine: From binding promiscuity to selective inhibition," 2021, UNC Libraries
  • "Preclinical models of soft tissue sarcomas - generation and applications to enhance translational research," 2025, Critical Reviews in Oncology/Hematology
  • "Establishment of patient-derived 3D in vitro models of sarcomas: literature review and guidelines on behalf of the FORTRESS working group," 2025, Neoplasia
  • "Genomics-led approach to drug testing in models of undifferentiated pleomorphic sarcoma," 2025, Molecular Oncology
  • "404 (PB392): Genomics-based approach to drug testing in novel patient-derived xenograft models of undifferentiated pleomorphic sarcoma," 2024, European Journal of Cancer

The frequent co-authors who have collaborated on multiple publications with Mary K. Danks include Piotr Manasterski, David S. Moura, Javier Martín-Broto, Morwenna Muir, and John C. Dawson.

Regarding publication venues, Mary K. Danks's research has appeared notably in:

  • European Journal of Cancer
  • Critical Reviews in Oncology/Hematology
  • Neoplasia
  • Molecular Oncology
  • UNC Libraries

Best Publications

  • Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumors

    Peter J. Houghton;Pamela J. Cheshire;James D. Hallman;Lois Lutz

  • Stem and progenitor cell-mediated tumor selective gene therapy

    K S Aboody;J Najbauer;M K Danks

  • Atypical multiple drug resistance in a human leukemic cell line selected for resistance to teniposide (VM-26).

    Mary K. Danks;Jack C. Yalowich;William T. Beck

  • Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26.

    Danks Mk;Schmidt Ca;Cirtain Mc;Suttle Dp

  • Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells.

    William T. Beck;M. C. Cirtain;M. K. Danks;R. L. Felsted

  • Studies on the Mechanism of Resistance to Rapamycin in Human Cancer Cells

    Hajime Hosoi;Michael B. Dilling;Linda N. Liu;Mary K. Danks

  • Proficient metabolism of irinotecan by a human intestinal carboxylesterase.

    Ruchi Khanna;Christopher L. Morton;Mary K. Danks;Philip M. Potter

  • Structural insights into CPT-11 activation by mammalian carboxylesterases.

    Sompop Bencharit;Christopher L. Morton;Escher L. Howard-Williams;Mary K. Danks

  • Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemic cells selected for resistance to teniposide.

    B Y Bugg;M K Danks;W T Beck;D P Suttle

  • Crystal structure of human carboxylesterase 1 complexed with the Alzheimer's drug tacrine: from binding promiscuity to selective inhibition.

    Sompop Bencharit;Christopher L Morton;Janice L Hyatt;Peter Kuhn

  • Identification and Characterization of Novel Benzil (Diphenylethane-1,2-dione) Analogues as Inhibitors of Mammalian Carboxylesterases

    Randy M. Wadkins;Janice L. Hyatt;Xin Wei;Kyoung Jin P. Yoon

  • Tumor-Targeted Enzyme/Prodrug Therapy Mediates Long-term Disease-Free Survival of Mice Bearing Disseminated Neuroblastoma

    Mary K. Danks;K. Jin Yoon;Rebecca A. Bush;Joanna S. Remack

  • p53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines

    Alan C. Taylor;Lili Shu;Mary K. Danks;Catherine A. Poquette

  • Comparison of activation of CPT-11 by rabbit and human carboxylesterases for use in enzyme/prodrug therapy.

    Mary K. Danks;Christopher L. Morton;Erik J. Krull;Pamela J. Cheshire

  • Development of a tumor-selective approach to treat metastatic cancer.

    Karen S. Aboody;Rebecca A. Bush;Elizabeth Garcia;Marianne Z. Metz

  • Brain tumor oncolysis with replication-conditional herpes simplex virus type 1 expressing the prodrug-activating genes, CYP2B1 and secreted human intestinal carboxylesterase, in combination with cyclophosphamide and irinotecan.

    Edyta Tyminski;Stanley LeRoy;Kinya Terada;Dianne M. Finkelstein

  • Overexpression of a Rabbit Liver Carboxylesterase Sensitizes Human Tumor Cells to CPT-11

    Mary K. Danks;Christopher L. Morton;Cynthia A. Pawlik;Philip M. Potter

  • The anticancer prodrug CPT-11 is a potent inhibitor of acetylcholinesterase but is rapidly catalyzed to SN-38 by butyrylcholinesterase.

    Christopher L. Morton;Randy M. Wadkins;Mary K. Danks;Philip M. Potter

  • New therapeutic targets for the treatment of high-risk neuroblastoma.

    Lars M. Wagner;Mary K. Danks

  • Discovery of Novel Selective Inhibitors of Human Intestinal Carboxylesterase for the Amelioration of Irinotecan-Induced Diarrhea: Synthesis, Quantitative Structure-Activity Relationship Analysis, and Biological Activity

    Randy M. Wadkins;Janice L Hyatt;Kyoung Jin P. Yoon;Christopher L. Morton

Frequent Co-Authors

Philip M. Potter
Philip M. Potter St. Jude Children's Research Hospital
William T. Beck
William T. Beck University of Illinois at Chicago
Peter J. Houghton
Peter J. Houghton The University of Texas Health Science Center at San Antonio
Clinton F. Stewart
Clinton F. Stewart St. Jude Children's Research Hospital
Seung U. Kim
Seung U. Kim University of British Columbia
Richard E. Lee
Richard E. Lee St. Jude Children's Research Hospital
Matthew R. Redinbo
Matthew R. Redinbo University of North Carolina at Chapel Hill
Marcus B. Valentine
Marcus B. Valentine St. Jude Children's Research Hospital
John D. Schuetz
John D. Schuetz St. Jude Children's Research Hospital
Janet A. Houghton
Janet A. Houghton Cleveland Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Mary K. Danks

Recently Published Articles